-
May 07, 2012
Onyx Pharmaceuticals Inc. (ONXX) recently announced that the U.S. Food and Drug Administration's (FDA) advisory ...
-
April 05, 2012
Fast growers are starting to outperform value stocks more sensitive to the economic climate, writes MoneyShow.com ...
-
February 15, 2012
Strong pipelines for the biotech sector as well as a wave of merger activity, have investors flocking to the stocks.
-
January 01, 2012
While the first half of 2012 is shaping up nicely, the second half is a bit worrisome, writes Elliott Gue of ...
-
November 02, 2011
Pfizer has to convince the Street that it can still grow, but the stock is cheap for now.
-
September 02, 2011
XOMA changes management again, but should anybody care?
-
August 24, 2011
Investors celebrate buybacks, but there is a cost to every decision.
-
August 15, 2011
There are a number of fundamental developments that have spurred recent purchases of Celgene.
-
July 27, 2011
Here are four drug stocks investors should watch heading into the second-half of the week.
-
June 20, 2011
Recent insider buying has driven interest in these stocks way up in the last few weeks.
-
June 07, 2011
Investors shouldn't be spooked by the normal post-ASCO sell-off
-
February 18, 2011
Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
-
December 28, 2010
Big biotechs had a mixed year, with concerns about R&D costs and product sales. The stocks may have seen the worst ...
-
August 12, 2010
These three stocks boast the highest percentage analyst buy ratings on the S&P 500.
-
July 02, 2010
If biotech companies are buying each other, should investors get in on the action?
-
June 30, 2010
Amgen is being treated like just another Big Pharma laggard, but analysis suggests there is more growth potential here.
-
June 22, 2010
Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
-
June 09, 2010
The recent pullback has provided insiders with the opportunity to pick up shares of their own stock at cheaper prices.
-
May 28, 2010
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.
-
March 09, 2010
With health care reform ever present in the news, what are the prospects for biotech firms?
